2nd Quarter - Report

OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC. for OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.

Period 2nd Quarter 2015 Filed Jul 20, 2015 Signed by John A. Bardi

Official filing
Firm
OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
Client
OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
Income
—
Expenses
$190,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Government Issues GOV

H.R.9 - Innovation Act

LobbyistCovered position, as disclosed
MOLLY RYAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 9 (114th)

Health Issues HCR

S.481 - Improving Regulatory Transparency for New Medical Therapies Act, H.R.6 - 21st Century Cures Act, H.R.2646 - Helping Families in Mental Health Crisis Act of 2015

LobbyistCovered position, as disclosed
MOLLY RYAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 481 (114th), H.R. 2646 (114th), H.R. 6 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.